{
    "article_link": "http://dx.doi.org/10.1136/gutjnl-2021-326070",
    "data": [
        {
            "id": "data_1",
            "omics": "Transcriptomics",
            "link": "https://www.noderepo.org/datasets/OEP003254",
            "format": "Single-cell RNA-seq",
            "source": "National Omics Data Encyclopedia (NODE)",
            "public_id": "OEP003254"
        },
        {
            "id": "data_2",
            "omics": "Proteomics",
            "link": "",
            "format": "DIA-MS",
            "source": "data-independent acquisition mass spectrometry (DIA-MS)",
            "public_id": ""
        },
        {
            "id": "data_3",
            "omics": "Metabolomics",
            "link": "",
            "format": "LC-MS/MS",
            "source": "LC-MS/MS",
            "public_id": ""
        },
        {
            "id": "data_4",
            "omics": "Transcriptomics",
            "link": "https://portal.gdc.cancer.gov/",
            "format": "Bulk RNA-seq",
            "source": "The Cancer Genome Atlas (TCGA)",
            "public_id": "TCGA-PAAD"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Single-cell RNA-seq",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_2",
            "analysis_name": "Cluster analysis",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_3",
            "analysis_name": "Pseudotime trajectory analysis",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_4",
            "analysis_name": "Cell-cell communication analysis",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_5",
            "analysis_name": "Gene regulatory network inference",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_6",
            "analysis_name": "Multi-omics analysis",
            "analysis_data": [
                "data_1",
                "data_2",
                "data_3"
            ],
            "label": null
        },
        {
            "id": "analysis_7",
            "analysis_name": "qPCR analysis",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_8",
            "analysis_name": "Spatial transcriptomics",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_9",
            "analysis_name": "Chromatin immunoprecipitation assay",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_10",
            "analysis_name": "Pathway enrichment analysis",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_11",
            "analysis_name": "Gene set variation analysis (GSVA)",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_12",
            "analysis_name": "Prognostic analysis",
            "analysis_data": [
                "data_1",
                "data_4"
            ],
            "label": {
                "TAN-1_signature": [
                    "high",
                    "low"
                ]
            }
        },
        {
            "id": "analysis_13",
            "analysis_name": "Flow cytometry analysis",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_14",
            "analysis_name": "Metabolomic analysis",
            "analysis_data": [
                "data_3"
            ],
            "label": null
        },
        {
            "id": "analysis_15",
            "analysis_name": "IHC Validation of BHLHE40+ TANs",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "BHLHE40_expression": [
                    "positive",
                    "negative"
                ]
            }
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_2",
            "metrics": "Number of Subclusters",
            "value": "4",
            "features": [
                "TAN-1",
                "TAN-2",
                "TAN-3",
                "TAN-4"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "Trajectory Length",
            "value": "1757 differentially expressed genes",
            "features": [
                "Glycolysis signature",
                "Hypoxia signature",
                "ER stress signature"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "Interaction Axes",
            "value": "",
            "features": [
                "CCL13-CCR1",
                "CCL3-CCR1",
                "CCL3L3-CCR1",
                "CXCL2-CXCR1",
                "CXCL2-CXCR2",
                "CXCL8-CXCR2"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "Regulon Activity",
            "value": "",
            "features": [
                "BHLHE40",
                "TAN-1 marker genes (VEGFA, PLAU, LGALS3, LDHA, PDE4B, IL1RN)",
                "TAN-2 marker genes (PDE4B, IL1RN)",
                "HIF1A/XBP1 Regulon Activity"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "Integrative Validation",
            "value": "Confirmed hyperactivated glycolytic activity in TAN-1 and metabolic reprogramming in PDAC",
            "features": [
                "Hyperactivated glycolytic activity in TAN-1",
                "Upregulated glycolysis in TAN-1 compared to other subclusters",
                "Glycolysis pathway enrichment in proteomics",
                "Increased glycolytic intermediates in metabolomics"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "Fold Change",
            "value": "Significantly upregulated in TAN-1 markers (e.g., VEGFA, PLAU, LGALS3, LDHA, PDE4B, IL1RN)",
            "features": [
                "VEGFA",
                "PLAU",
                "LGALS3",
                "LDHA",
                "PDE4B",
                "IL1RN",
                "IFIT2",
                "ISG15",
                "RSAD2",
                "BHLHE40"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "Spatial Distribution",
            "value": "",
            "features": [
                "VEGFA+ TANs",
                "NLRP3+ TANs",
                "MME+ TANs",
                "IFIT2+ TANs"
            ]
        },
        {
            "analysis_id": "analysis_9",
            "metrics": "Direct Regulation",
            "value": "",
            "features": [
                "Binding of BHLHE40 to promoter regions of VEGFA, PLAU, LGALS3, LDHA, PDE4B, IL1RN"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "Enrichment Score",
            "value": "High in glycolysis, hypoxia, ER stress, and IL-1/NF-κB pathways",
            "features": [
                "Glycolysis",
                "Hypoxia",
                "ER Stress",
                "IL-1/NF-κB Signaling"
            ]
        },
        {
            "analysis_id": "analysis_11",
            "metrics": "Enrichment Score",
            "value": "High in TAN-1 signature and BHLHE40+ TANs",
            "features": [
                "VEGFA+ TANs",
                "BHLHE40+ TANs"
            ]
        },
        {
            "analysis_id": "analysis_12",
            "metrics": "Overall Survival",
            "value": "Poor prognosis in TAN-1 signature-positive patients",
            "features": [
                "TAN-1 signature as an unfavourable prognostic factor in PDAC",
                "BHLHE40+ TANs"
            ]
        },
        {
            "analysis_id": "analysis_13",
            "metrics": "Mean Fluorescence Intensity (MFI)",
            "value": "Increased in LGALS3+ TANs for GLUT1, HK2, PFKFB3, and LDHA",
            "features": [
                "GLUT1",
                "HK2",
                "PFKFB3",
                "LDHA"
            ]
        },
        {
            "analysis_id": "analysis_14",
            "metrics": "Metabolite Abundance",
            "value": "Significantly increased in TANs for glycolytic intermediates (e.g., lactate, pyruvate)",
            "features": [
                "Glycolytic intermediates (lactate, pyruvate)"
            ]
        },
        {
            "analysis_id": "analysis_15",
            "metrics": "Prognostic Association",
            "value": "Higher infiltration of BHLHE40+ TANs correlates with worse prognosis",
            "features": [
                "BHLHE40+ TANs",
                "Co-localization with VEGFA+ TANs in PDAC microenvironment"
            ]
        }
    ]
}